Cargando…

An MRI radiomics approach to predict survival and tumour-infiltrating macrophages in gliomas

Preoperative MRI is one of the most important clinical results for the diagnosis and treatment of glioma patients. The objective of this study was to construct a stable and validatable preoperative T(2)-weighted MRI-based radiomics model for predicting the survival of gliomas. A total of 652 glioma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Guanzhang, Li, Lin, Li, Yiming, Qian, Zenghui, Wu, Fan, He, Yufei, Jiang, Haoyu, Li, Renpeng, Wang, Di, Zhai, You, Wang, Zhiliang, Jiang, Tao, Zhang, Jing, Zhang, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9050568/ https://www.ncbi.nlm.nih.gov/pubmed/35136934 http://dx.doi.org/10.1093/brain/awab340

Ejemplares similares

A novel methylation signature predicts radiotherapy sensitivity in glioma
por: Feng, Yuemei, et al.
Publicado: (2020)

Postoperative standard chemoradiotherapy benefits primary glioblastoma patients of all ages
por: Li, Guanzhang, et al.
Publicado: (2019)

Single-Cell RNA-Sequencing Shift in the Interaction Pattern Between Glioma Stem Cells and Immune Cells During Tumorigenesis
por: Zhai, You, et al.
Publicado: (2020)

Functional clustering analysis identifies specific subtypes of aldehyde dehydrogenase associated with glioma immunity
por: Wang, Di, et al.
Publicado: (2021)

A novel gene signature based on five immune checkpoint genes predicts the survival of glioma
por: Zhang, Wei, et al.
Publicado: (2021)

NK Cell-Based Immunotherapy and Therapeutic Perspective in Gliomas
por: Pan, Changqing, et al.
Publicado: (2021)

Radiogenomics of lower-grade gliomas: a radiomic signature as a biological surrogate for survival prediction
por: Qian, Zenghui, et al.
Publicado: (2018)

Identification of IDH-mutant gliomas by a prognostic signature according to gene expression profiling
por: Wang, Qiangwei, et al.
Publicado: (2018)

Uronic acid metabolic process–related gene expression–based signature predicts overall survival of glioma
por: Feng, Yuemei, et al.
Publicado: (2021)

A radiomic signature as a non-invasive predictor of progression-free survival in patients with lower-grade gliomas
por: Liu, Xing, et al.
Publicado: (2018)

Expression profile analysis of antisense long non-coding RNA identifies WDFY3-AS2 as a prognostic biomarker in diffuse glioma
por: Wu, Fan, et al.
Publicado: (2018)

Comparative profiling of immune genes improves the prognoses of lower grade gliomas
por: Wang, Zhiliang, et al.
Publicado: (2022)

Comprehensive Analysis of the Clinical and Biological Significances of Endoplasmic Reticulum Stress in Diffuse Gliomas
por: Huang, Ruoyu, et al.
Publicado: (2021)

Corrigendum: Comprehensive analysis of the clinical and biological significances of endoplasmic reticulum stress in diffuse gliomas
por: Huang, Ruoyu, et al.
Publicado: (2022)

IDH mutation-specific radiomic signature in lower-grade gliomas
por: Liu, Xing, et al.
Publicado: (2019)

MRI features predict p53 status in lower-grade gliomas via a machine-learning approach
por: Li, Yiming, et al.
Publicado: (2017)

RPP30, a transcriptional regulator, is a potential pathogenic factor in glioblastoma
por: Li, Guanzhang, et al.
Publicado: (2020)

TREM2 is associated with tumor immunity and implies poor prognosis in glioma
por: Yu, Mingchen, et al.
Publicado: (2023)

ATRX, IDH1-R132H and Ki-67 immunohistochemistry as a classification scheme for astrocytic tumors
por: Cai, Jinquan, et al.
Publicado: (2016)

WES data from 286 diffuse gliomas under the 2021 WHO Classification of Tumors of the Central Nervous System
por: Zhao, Zheng, et al.
Publicado: (2022)

A novel DNA repair‐related nomogram predicts survival in low‐grade gliomas
por: Li, Guanzhang, et al.
Publicado: (2020)

Redox Regulator GLRX Is Associated With Tumor Immunity in Glioma
por: Chang, Yuanhao, et al.
Publicado: (2020)

Clinical characterization and immunosuppressive regulation of CD161 (KLRB1) in glioma through 916 samples
por: Di, Wang, et al.
Publicado: (2021)

Detection of ATRX and IDH1-R132H immunohistochemistry in the progression of 211 paired gliomas
por: Cai, Jinquan, et al.
Publicado: (2016)

Identification of an ATP metabolism‐related signature associated with prognosis and immune microenvironment in gliomas
por: Huang, Ruoyu, et al.
Publicado: (2020)

Tumour-infiltrating CD4(+) and CD8(+) lymphocytes as predictors of clinical outcome in glioma
por: Han, S, et al.
Publicado: (2014)

Noninvasive Determination of the IDH Status of Gliomas Using MRI and MRI-Based Radiomics: Impact on Diagnosis and Prognosis
por: Li, Yurong, et al.
Publicado: (2022)

Exploring MRI Characteristics of Brain Diffuse Midline Gliomas With the H3 K27M Mutation Using Radiomics
por: Li, Qian, et al.
Publicado: (2021)

Grading of Gliomas by Using Radiomic Features on Multiple Magnetic Resonance Imaging (MRI) Sequences
por: Qin, Jiang-bo, et al.
Publicado: (2017)

Molecular Characterization and Clinical Relevance of ANXA1 in Gliomas via 1,018 Chinese Cohort Patients
por: Qian, Zenghui, et al.
Publicado: (2021)

Application of radiomics feature captured from MRI for prediction of recurrence for glioma patients
por: Liu, Canyu, et al.
Publicado: (2022)

MEGF10, a Glioma Survival-Associated Molecular Signature, Predicts IDH Mutation Status
por: Li, Guanzhang, et al.
Publicado: (2018)

Molecular and clinical characterization of PD-L1 expression at transcriptional level via 976 samples of brain glioma
por: Wang, Zheng, et al.
Publicado: (2016)

Prediction of high infiltration levels in pituitary adenoma using MRI-based radiomics and machine learning
por: Zhang, Chao, et al.
Publicado: (2022)

A novel chemokine‐based signature for prediction of prognosis and therapeutic response in glioma
por: Fan, Wenhua, et al.
Publicado: (2022)

Application of Enhanced T1WI of MRI Radiomics in Glioma Grading
por: Zhou, Hongzhang, et al.
Publicado: (2022)

Preoperative Radiomics Analysis of 1p/19q Status in WHO Grade II Gliomas
por: Fan, Ziwen, et al.
Publicado: (2021)

Genetic and clinical characterization of B7‐H3 (CD276) expression and epigenetic regulation in diffuse brain glioma
por: Wang, Zhiliang, et al.
Publicado: (2018)

EFEMP2 indicates assembly of M0 macrophage and more malignant phenotypes of glioma
por: Huang, Lijie, et al.
Publicado: (2020)

Quantitative MRI-based radiomics for noninvasively predicting molecular subtypes and survival in glioma patients
por: Yan, Jing, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_87d5qni2fab0fgpho05qdnsuqp